Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/ Spondyloarthritis Registry

by Blachley, T., Dube, B., Hur, P., Kim, N., McLean, R.R, Mease, P.J, Ogdie, A.
Published 2022

Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis

by Bergman, M., Gladman, D.D, Jardon, S., Kavanaugh, A., Mease, P.J, Ogdie, A., Richter, S., Smolen, J.S, Teng, L., Wells, A.F
Published 2022

Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: Pooled results through week 5...

by Boehncke, W.-H, Chakravarty, S.D, Deodhar, A., Jiang, Y., Kollmeier, A.P, McInnes, I.B, Mease, P.J, Merola, J.F, Ritchlin, C.T, Schiopu, E., Shawi, M., Sheng, S., Tesser, J., Wang, Y., Xu, S., Xu, X.L
Published 2022